MedPath

AUT-002006

Generic Name
AUT-002006

Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.

Phase 1
Completed
Conditions
Schizophrenia
Interventions
Drug: Placebo
First Posted Date
2017-05-24
Last Posted Date
2020-07-31
Lead Sponsor
Autifony Therapeutics Limited
Target Recruit Count
24
Registration Number
NCT03164876
Locations
🇬🇧

King's College London Institute of Psychiatry, Psychology and Neuroscience (IoPPN), London, United Kingdom

Safety, Blood Levels and Effects of AUT00206

Phase 1
Completed
Conditions
Schizophrenia
First Posted Date
2015-10-28
Last Posted Date
2016-10-14
Lead Sponsor
Autifony Therapeutics Limited
Registration Number
NCT02589262
Locations
🇬🇧

Hammersmith Medicines Research, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath